<DOC>
	<DOCNO>NCT00562848</DOCNO>
	<brief_summary>Motilin peptide whose action control motilin receptor locate gut . Action Motilin motilin receptor increase gastric empty rate ( rate empty food fluid stomach ) . Compounds stimulate motilin receptor therefore provide potential approach treatment range clinical condition delay gastric emptying may contribute symptom , enteral feeding intolerance ( post-operative intensive care patient ) , gastroparesis , diabetic gastroparesis , functional dyspepsia . This study First Time In Human study motilin receptor agonist , GSK962040 .</brief_summary>
	<brief_title>A Study Evaluate Safety , Side Effects , Muscle Activity Speed Gastric Emptying GSK962040</brief_title>
	<detailed_description />
	<mesh_term>Gastroparesis</mesh_term>
	<criteria>Healthy male female subject age 18 55 year inclusive . Healthy subject define individual free clinically significant illness disease determine medical history ( include family ) , physical examination , laboratory study , test . A female subject may enrol study regardless whether currently nonchildbearing potential childbearing potential , long follow condition observe : Females nonchildbearing potential : These define female , regardless age , function ovary current document tubal ligation [ Hatcher , 2004 ] hysterectomy , females postmenopausal . Females childbearing potential : These define female , regardless age , function ovary document impairment oviductal uterine function would cause sterility . This category include female oligomenorrhea female perimenopausal . To eligible study , female childbearing potential must negative pregnancy test screen enrolment study ; must agree use one highly effective method avoid pregnancy protocol , Screening Visit throughout duration study include followup clinic visit , anticipate take place 710 day last dose study medication ( however time followup visit may adjust File Note indicate interim PK analysis ) . At stage development , information potential pharmacokinetic interaction GSK962040 hormonal birth control method , hormonal method acceptable . A 12lead ECG prestudy screening , opinion Principal Investigator physician designee abnormality compromise safety study . QT/QTc criterion define protocol . A 24h Holter ECG prestudy screen opinion Principal Investigator physician designee abnormality compromise safety study . Normal physical examination ( physical exam demonstrate evidence clinically active disease physical mental impairment ) . No abnormality relevant clinical chemistry haematology examination prestudy medical examination . Body weight â‰¥50 kg BMI within range 18.529.9 kg/m2 inclusive BMI = Weight kg ( height meter ) 2 The volunteer able understand comply protocol requirement , instruction protocolstated restriction . Signed date write informed consent prior performance study related procedure . Subjects negative Helicobacter pylorus status receive eradication within last calendar year . Use hormonal method contraception form HRT ( female subject ) . History presence clinically significant metabolic , gastrointestinal endocrinological condition . History presence clinically significant gastrointestinal , hepatic renal disease condition know interfere absorption , distribution , metabolism excretion drug . History major gastrointestinal surgical procedure within last 10 year . History cholecystectomy biliary tract disease . History immediate delay hypersensitivity reaction idiosyncrasy drug , allergy , opinion Principal Investigator physician designee , contraindicate subject 's participation study . Additionally subject know latex allergy enrol C3 . History presence correct thyroid dysfunction ( NOTE : subject hypothyroidism stable dose thyroid replacement therapy eligible ) . Abnormal TSH free T4 screening/baseline . Unwillingness commit avoid excessive exposure sunlight ( exposure whilst tan bed ) would cause sunburn reaction Day 1 include followup visit . A positive prestudy HIV , Hepatitis B surface antigen positive Hepatitis C antibody result screen . History presence abuse alcohol define average weekly intake great 21 unit average daily intake great 3 unit . History presence recreational drug abuse dependence . The subject positive predose urine drug alcohol breath test . A minimum list drug screen include Amphetamines , Barbiturates , Cocaine , Opiates , Cannabinoids Benzodiazepines . If subject tobacco smoker : An unwillingness commit stable moderate use ( determined Investigator ) tobacco nicotinecontaining product , include nicotine patches/gum , course study . Consumption grapefruit juice grapefruit within 7 day prior first dose study medication followup visit . Use prescription nonprescription drug , include vitamin , herbal dietary supplement ( include St John 's Wort ) within 3 week prior first dose study medication final evaluation , unless opinion Investigator sponsor medication interfere study procedure compromise subject safety . Has receive investigational drug participate research trial within 30 day 5 halflives , twice duration biological effect drug ( whichever longer ) prior first dose study medication . Exposure four new chemical entity within 12 month prior first dose day . Where participation study would result donation blood excess 500 ml within 56 day period . For male volunteer : An unwillingness male subject use condom/spermicide addition female partner use another form contraception IUD , diaphragm spermicide , oral contraceptive , injectable progesterone , subdermal implant tubal ligation woman could become pregnant time first dose study medication 90 day follow administration last dose study medication . History current lactose intolerance . Women pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>gastric empty</keyword>
	<keyword>pharmacokinetic</keyword>
	<keyword>tolerability</keyword>
	<keyword>safety</keyword>
	<keyword>GSK962040</keyword>
	<keyword>gut motility</keyword>
	<keyword>First Time Human</keyword>
</DOC>